Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2

Anti–vascular endothelial growth factor (VEGF) therapy has failed to improve survival in patients with breast cancer (BC). Potential mechanisms of resistance to anti-VEGF therapy include the up-regulation of alternative angiogenic and proinflammatory factors. Obesity is associated with hypoxic adipo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Transl Med
Autors principals: Incio, Joao, Ligibel, Jennifer A., McManus, Daniel T., Suboj, Priya, Jung, Keehoon, Kawaguchi, Kosuke, Pinter, Matthias, Babykutty, Suboj, Chin, Shan M., Vardam, Trupti D., Huang, Yuhui, Rahbari, Nuh N., Roberge, Sylvie, Wang, Dannie, Gomes-Santos, Igor L., Puchner, Stefan B., Schlett, Christopher L., Hoffmman, Udo, Ancukiewicz, Marek, Tolaney, Sara M., Krop, Ian E., Duda, Dan G., Boucher, Yves, Fukumura, Dai, Jain, Rakesh K.
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5936748/
https://ncbi.nlm.nih.gov/pubmed/29540614
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.aag0945
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars